“Novel Clinical Manifestations of Human Monkeypox Virus Infection and Current Therapeutic and Preventive Strategies: A Systematic Review “
Preprint
Abstract
The escalating global monkeypox cases since early May 2022, acquired by the monkeypox virus (MPXV), a double-stranded DNA virus has been declared a public health emergency of international concern by the World Health Organization (WHO). Globally as of December 2022, the MPXV was transmitted to more than 100 countries with around 82,550 cases, among which 81577 cases from the 103 countries that are non-endemic to the MPXV with more than 50 deaths. The ripple effect of the Monkeypox outbreak in nonendemic countries globally could potentially bring significant challenges to worldwide health systems if the spread of the virus is not effectively controlled. In this urgent situation, only three antiviral drugs are in use against monkeypox infections and are not specific against monkeypox, hence the scientific communities across the world are in search to explore vaccines or therapeutic antiviral drugs selectively against the monkeypox virus. Here, in the present review, we discuss the clinical characteristics and treatment outcomes of the ongoing MPX outbreak of 2022 in nonendemic countries globally, from the published and grey literature in PubMed, Scopus and Google scholar. A total of 17 studies with 17,811 of MPX cases were found and included in the final qualitative analysis of the current systematic review.Keywords
This publication has 45 references indexed in Scilit:
- Evaluation of Therapeutic Interventions for Vaccinia Virus KeratitisThe Journal of Infectious Diseases, 2011
- Cidofovir Activity against Poxvirus InfectionsViruses, 2010
- ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose JustificationAntimicrobial Agents and Chemotherapy, 2009
- Clinical Manifestations of Human Monkeypox Influenced by Route of InfectionThe Journal of Infectious Diseases, 2006
- Reemergence of Monkeypox: Prevalence, Diagnostics, and CountermeasuresClinical Infectious Diseases, 2005
- Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe DiseaseClinical Infectious Diseases, 2005
- Clinical Efficacy of Intramuscular Vaccinia Immune Globulin: A Literature ReviewClinical Infectious Diseases, 2004
- Smallpox Vaccination: A Review, Part II. Adverse EventsClinical Infectious Diseases, 2003
- The Transmission Potential of Monkeypox Virus in Human PopulationsInternational Journal of Epidemiology, 1988
- Human Monkeypox: Clinical Features of 282 PatientsThe Journal of Infectious Diseases, 1987